CD274 and neoplasm: In multivariate analysis with Cox proportional hazards regression method, we found that patients with PD-L1 expression on ≥1% of tumor cells compared to patients without PD-L1 expression on cancer cells had a significantly lower risk of progression (HR=0.3857, 95% CI: 0.1612–0.9226, p=0.0323).